|
|
Volumn 34, Issue 5, 2002, Pages 1511-1513
|
|
Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
a,b
c
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
DACLIZUMAB;
DRUG DERIVATIVE;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID;
ADULT;
ANEMIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMATOLOGIC DISEASE;
HUMAN;
HUMAN TISSUE;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DISEASE;
LEUKOPENIA;
LIVER BIOPSY;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEUROTOXICITY;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RECIPIENT;
SURVIVAL RATE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ARTICLE;
COMPARATIVE STUDY;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FOLLOW UP;
IMMUNOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
TIME;
ANTIBODIES, MONOCLONAL;
COMPARATIVE STUDY;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGE;
MYCOPHENOLIC ACID;
PROSPECTIVE STUDIES;
TACROLIMUS;
TIME FACTORS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035993612
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02951-2 Document Type: Conference Paper |
|
Times cited : (15)
|
|
References (11)
|
